Copper‐Induced Supramolecular Peptide Assemblies for Multi‐Pathway Cell Death and Tumor Inhibition

Author:

Zhang Xiangyang12,Zhang Buyue12,Zhang Ying12,Ding Yinghao12,Zhang Zhenghao12,Liu Qian3,Yang Zhimou124,Wang Ling12,Gao Jie12ORCID

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai International Advanced Research Institute (SHENZHEN⋅FUTIAN) Nankai University Tianjin 300071 China

2. Key Laboratory of Bioactive Materials Ministry of Education, College of Life Sciences Tianjin 300071 China

3. Department of Urology Tianjin First Central Hospital Tianjin 300192 China

4. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute Xuzhou Medical University Xuzhou Jiangsu 221002 China

Abstract

AbstractAlthough self‐assembly has emerged as an effective tool for fabricating biomaterials, achieving precise control over the morphologies and functionalities of the resultant assemblies remains an ongoing challenge. Inspired by the copper peptide naturally present in human plasma, in this study, we designed a synthetic precursor, FcGH. FcGH can self‐assemble via two distinct pathways: spontaneous and Cu2+‐induced. These two assembly pathways enabled the formation of assemblies with tunable morphologies by adjusting the amount of added Cu2+. We found that the nanoparticles formed by Cu2+‐induced self‐assembly exhibited a significantly higher cellular uptake efficiency than the wormlike fibers formed spontaneously. Moreover, this Cu2+‐induced assembly process occurred spontaneously at a 1 : 1 molar ratio of Cu2+ to FcGH, avoiding the excessive use of Cu2+ and a tedious preparation procedure. By co‐assembling with 10‐hydroxycamptothecin (HCPT)‐conjugated FcGH, Cu2+‐induced supramolecular nanodrugs elicited multiple cell death modalities in cancer cells with elevated immunogenicity, enhancing the therapeutic effect compared to free HCPT. This study highlights Cu2+‐induced self‐assembly as an efficient tool for directing the assembly of nanodrugs and for synergistic tumor therapy.

Funder

National Key Research and Development Program of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3